How a USPSTF Letter Grade Is Actually Decided

Every USPSTF letter grade encodes two separate judgments rather than one: how confident the Task Force is that its estimate of a service's net benefit is correct, which it calls certainty, and how large that net benefit actually is, its magnitude. A grade of A or B reflects enough certainty to recommend a service whose net benefit is at least moderate. An I statement means the evidence is too thin, flawed, or conflicting to judge the balance of benefits and harms at all. That last point is the one most often misread: an I statement reports uncertainty, not a verdict against a service.

Two axes, not a single score

The Task Force's methods documentation defines net benefit precisely as the benefit minus the harm of a preventive service as delivered in a general primary care population. Certainty is defined separately as the likelihood that the Task Force's assessment of that net benefit is correct. These are independent questions. You can be highly certain that a benefit is small, or quite uncertain about something that might be large. Collapsing the two into a single "good or bad" impression is where most misreadings of a grade begin.

Magnitude is sorted into four bins: substantial, moderate, small, or zero to negative. Certainty is sorted into three: high, moderate, or low. The letter grade is what you get when those two axes intersect.

How certainty is built

Certainty does not come from a single trial. The Task Force lays out an analytic framework, essentially a diagram that connects the population being screened to the health outcomes that matter, passing through any intermediate steps and potential harms along the way. Each arrow in that diagram is a key question, and each key question has to be supported by evidence for the whole chain to hold.

For every key question, reviewers weigh six things: whether the study design fits the question, the internal validity or quality of the studies, how well the findings generalize to routine U.S. primary care, the number and size and precision of the studies, the consistency of results across them, and supporting considerations such as dose-response gradients or biological plausibility. The body of evidence for each link is then rated convincing, adequate, or inadequate. A chain is only as strong as its weakest supported link, so a single inadequate step can cap the certainty of an entire recommendation.

The three levels of certainty

High certainty rests on consistent results from well-designed studies in representative primary care populations, where new research is unlikely to change the conclusion. Moderate certainty means the evidence is enough to reach a conclusion, but confidence is limited by factors such as inconsistency, weaker generalizability, or gaps in the chain, so future findings could shift the estimate. Low certainty means the evidence is insufficient, whether because studies are few, flawed, inconsistent, or missing the links to actual health outcomes.

How magnitude is estimated

To size the net benefit, the Task Force builds outcome tables that project real health outcomes for a hypothetical population, one version receiving the service and one not. Benefits and harms are estimated in those same concrete terms, then weighed against each other and placed into one of the four magnitude categories. The point of the table is to force the benefit and the harm onto the same scale before anyone talks about a letter.

The grid that produces the grade

Put certainty on one axis and magnitude on the other, and the published grade definitions fall out of the grid. High certainty of a substantial benefit yields an A. High certainty of a moderate benefit, or moderate certainty of a moderate-to-substantial benefit, yields a B. At least moderate certainty of a small benefit yields a C, which is why a C is a recommendation to offer the service selectively rather than routinely, guided by individual circumstances. Moderate or high certainty that a service has no net benefit, or that its harms outweigh its benefits, yields a D, a recommendation against.

Low certainty behaves differently. Whenever certainty is low, no matter how large the benefit might eventually prove to be, the result is not a letter grade at all. It is an I statement.

Why an I statement is not a "no"

This is the distinction worth holding onto. A D grade is an active recommendation against a service, grounded in reasonable confidence that it does not help or that it causes net harm. An I statement says the Task Force cannot yet determine the balance of benefits and harms because the evidence is lacking, of poor quality, or conflicting. A D reflects knowledge; an I reflects the absence of it. Treating an I as if it were a D reads a firm "stop" into what is really a "we do not yet know," and it can wrongly discredit services that simply have not been studied adequately.

Why the grade travels beyond the exam room

Part of why the grades carry weight is legal, beyond clinical convention. Under the Task Force's congressional mandate and the coverage provisions attached to it, services rated A or B are the ones private health plans, and through a separate provision many Medicaid programs, are required to cover without patient cost-sharing. That structure explains why the A-versus-B line and the B-versus-I line matter so much in practice, and why the two-axis logic behind each grade rewards understanding rather than reduction to a thumbs up or thumbs down. This article is educational and not medical advice.